[go: up one dir, main page]

ES545368A0 - Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina. - Google Patents

Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina.

Info

Publication number
ES545368A0
ES545368A0 ES545368A ES545368A ES545368A0 ES 545368 A0 ES545368 A0 ES 545368A0 ES 545368 A ES545368 A ES 545368A ES 545368 A ES545368 A ES 545368A ES 545368 A0 ES545368 A0 ES 545368A0
Authority
ES
Spain
Prior art keywords
dimetoxiquinazoline
furoil
mino
piperazin
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545368A
Other languages
English (en)
Other versions
ES8707447A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES545368A0 publication Critical patent/ES545368A0/es
Publication of ES8707447A1 publication Critical patent/ES8707447A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES545368A 1976-03-01 1977-02-28 Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina. Expired ES8707447A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,937 US4092315A (en) 1976-03-01 1976-03-01 Novel crystalline forms of prazosin hydrochloride

Publications (2)

Publication Number Publication Date
ES545368A0 true ES545368A0 (es) 1978-06-01
ES8707447A1 ES8707447A1 (es) 1987-08-16

Family

ID=24659839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545368A Expired ES8707447A1 (es) 1976-03-01 1977-02-28 Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina.

Country Status (32)

Country Link
US (1) US4092315A (es)
JP (1) JPS604188B2 (es)
AR (1) AR210937A1 (es)
AU (1) AU506937B2 (es)
BE (1) BE851878A (es)
BG (1) BG29724A3 (es)
CA (1) CA1068269A (es)
CH (1) CH618436A5 (es)
CS (1) CS191332B2 (es)
DD (1) DD129652A5 (es)
DE (1) DE2708192C3 (es)
DK (1) DK145858C (es)
ES (1) ES8707447A1 (es)
FI (1) FI62082C (es)
FR (1) FR2372828A1 (es)
GB (1) GB1538713A (es)
HK (1) HK30881A (es)
HU (1) HU173641B (es)
IE (1) IE44522B1 (es)
IL (1) IL51481A (es)
LU (1) LU76868A1 (es)
MY (1) MY8100271A (es)
NL (1) NL169591C (es)
NO (1) NO146499C (es)
NZ (1) NZ183450A (es)
PL (1) PL105559B1 (es)
PT (1) PT66227B (es)
RO (1) RO73095A (es)
SE (1) SE423234B (es)
SU (1) SU644387A3 (es)
YU (1) YU41294B (es)
ZA (1) ZA77918B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX5483E (es) * 1977-08-04 1983-08-23 Abbott Lab Procedimiento para la preparacion del dihidrato clorhidrato de 1-(4-amino-6,7-dimetoxi-2-quinazolinil)-4-(2-tetrahidrofuroil)piperazina
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4197301A (en) * 1978-10-16 1980-04-08 Allergan Pharmaceuticals, Inc. Topical ophthalmic use of Prazosin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4440769A (en) * 1983-02-11 1984-04-03 Abbott Laboratories 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US5322943A (en) * 1985-09-12 1994-06-21 The Upjohn Company Piperazine compounds which are substituted
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 1−(4−アミノ−6,7−ジメトキシ−2−キナゾリニル)−4−(2−テトラヒドロフロイル)ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849266B8 (de) * 1996-12-20 2007-10-03 Heumann PCS GmbH Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP3172377B1 (en) 2014-07-21 2018-09-12 KEIR Manufacturing, Inc. Aerodynamic flyer bow

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents

Also Published As

Publication number Publication date
HU173641B (en) 1979-07-28
CH618436A5 (es) 1980-07-31
BE851878A (fr) 1977-08-29
IL51481A0 (en) 1977-04-29
DE2708192B2 (de) 1979-08-02
FI62082B (fi) 1982-07-30
NL169591B (nl) 1982-03-01
FI770634A (es) 1977-09-02
YU41294B (en) 1987-02-28
DE2708192A1 (de) 1977-09-08
FR2372828A1 (fr) 1978-06-30
DK145858C (da) 1983-09-12
NZ183450A (en) 1979-03-16
CS191332B2 (en) 1979-06-29
JPS604188B2 (ja) 1985-02-01
NO770674L (no) 1977-09-02
CA1068269A (en) 1979-12-18
PL196354A1 (pl) 1978-02-27
FI62082C (fi) 1982-11-10
ES8707447A1 (es) 1987-08-16
SE7701624L (sv) 1977-09-02
DK145858B (da) 1983-03-21
PL105559B1 (pl) 1979-10-31
SU644387A3 (ru) 1979-01-25
NO146499C (no) 1982-10-13
GB1538713A (en) 1979-01-24
NL169591C (nl) 1982-08-02
DK86877A (da) 1977-09-02
HK30881A (en) 1981-07-10
PT66227B (en) 1978-07-14
FR2372828B1 (es) 1980-02-01
ZA77918B (en) 1977-12-28
DE2708192C3 (de) 1980-05-08
DD129652A5 (de) 1978-02-01
JPS52105206A (en) 1977-09-03
BG29724A3 (en) 1981-01-15
AU2244377A (en) 1978-11-23
NL7702123A (nl) 1977-09-05
RO73095A (ro) 1981-06-26
LU76868A1 (es) 1977-09-21
US4092315A (en) 1978-05-30
IE44522B1 (en) 1981-12-30
AR210937A1 (es) 1977-09-30
MY8100271A (en) 1981-12-31
PT66227A (en) 1977-03-01
YU49977A (en) 1983-12-31
IL51481A (en) 1980-09-16
IE44522L (en) 1977-09-01
SE423234B (sv) 1982-04-26
NO146499B (no) 1982-07-05
AU506937B2 (en) 1980-01-31

Similar Documents

Publication Publication Date Title
ES545368A0 (es) Un procedimiento para la preparacion de la forma alfa cris- talina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-a-mino-6,7-dimetoxiquinazolina.
ES491534A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol.
AR224008A1 (es) Procedimiento para preparar polihidro-3,7-dimetil-8-(2-(tetrahidro-4-hidroxi-6-oxo-2h-piran-2-il)-etil)-1-naftil-2-metilbutirato
ES226784Y (es) Un dispositivo para el acoplamiento de elementos desmonta- bles.
NL7711788A (nl) Nieuwe gibberellinezouten.
ES498020A0 (es) Un procedimiento para al preparacion de un ce)-5-(halogenovinil)-arabino-furano-siluracilo.
ES496661A0 (es) Procedimiento para la fabricacion de un tejido, en especial de una cinta tejida.
AR211080A1 (es) Procedimiento mejorado para fabricar embutidus.
ES506281A0 (es) Un procedimiento para la preparacion de 4-(4-imidazolil)piridinas 2-sustituidas.
AR213659A1 (es) Procedimiento para la preparacion de 2-(4-(aroil o heteroaroil)-piperazin-1-il)-4-amino-6,7-dimetoxiquinazolinas
IT1084503B (it) Procedimento per la preparazione di una poliolefina.
DK140578A (da) Fremgangsmaade til fremstilling af 2-(2!,2!,-trihalogenethyl)-4-halogencyclobutan-1-oner.
AR208612A1 (es) Un procedimiento para la fabricacion de escobas cepillos o implementos similares
ES510236A0 (es) Procedimiento para preparar compuestos azoicos.
ES488797A0 (es) Un procedimiento para la preparacion de cloruro de 2-(p-hi- droxi-fenil)glicilo.
AR214527A1 (es) Procedimiento para la preparacion de-n-6-cloronicotionoil-d,1 homocisteina tiolactona
AR211410Q (es) Procedimiento para preparar 2-(2,2- diciclohexietil)piperidina
FI830278L (fi) Som mellanprodukter anvaendbara 2-(2-aminotiazol-4-yl)-2-oxiiminoaettiksyrederivat
ES220957Y (es) Calzo para mobiliario.
ES218652Y (es) Utensilio para la colocacion de junquillos.
ES219543Y (es) Protector para calzado femenino.
ES219312Y (es) Partesoles para fachadas.
AR209605A1 (es) Un procedimiento para la obtencion de la 2-(3,4,5-trimetoxibencil)3,4-dimetilpiridina
AR204361A1 (es) Procedimiento para la preparacion de un 2-(2',6'-dihalofenil)-amino-2-imidazolina y sus sales
ES225114Y (es) Pieza ceramica para fachadas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001